A classification of antiarrhythmic drugs based on the Na^+ channel blocking properties directly assessed by the cardiac Na^+ current recordings

基于通过心脏 Na^ 电流记录直接评估的 Na^ 通道阻断特性的抗心律失常药物的分类

基本信息

项目摘要

There have been considerable variation as to the subclassification of the class I antiarrhythmic drugs depending on the methodology to assess the drug actions, different preparations and individual reporters. As a possible reason for the above confusion, most of the reports dealt with the Na^+ channel block as assessed by measuring V_<max> of action potentials, an indirect index of the Na^+ channel availability rather than the current measurement. Therefore we tried to explore the modes of the Na^+ channel block by class I antiarrhythmic drugs directly assessed by the recordings of the cardiac Na^+ current using the patch-clamp technique and to obtain a new classification of the drugs based on the results. We used isolated ventricular myocytes from guinea-pig hearts by collagenase treatment. The Na^+ currents were recorded by the patch-clamp technique of whole-cell configuration, cell-attached and inside-out patch configurations, Disopyramide, I_a agent, produced used-dependent block of the Na^+ current with two exponential functions, fast and slow component. It was further shown by the experiments conducted under different external pH that the slow block process was caused by ionized form of the drug having affinity to bind the activated state of the Na^+ channel, while the fast process was produced by the non-ionized form to the activated state of the channel. The fast and slow block fractions consisted nearly equal degrees. Lidocaine, I_b agent, also caused two exponential block developments, while the major portion of the block development was brought by the fast fraction with small part by the slow component. The fast block was made by the non-ionized drug to bind the inactivated state of the channel and the slow block was caused by the ionized drug to the activated state of the channel. Mexyletine also caused two exponential block development as similar to lidocaine. The ionized mexiletine pr
根据评估药物作用的方法、不同的制剂和个体报告者,I 类抗心律失常药物的细分存在相当大的差异。作为上述混乱的可能原因,大多数报告涉及通过测量动作电位的 V_<max> 来评估 Na^+ 通道阻滞,这是 Na^+ 通道可用性的间接指标,而不是当前测量。因此,我们尝试通过膜片钳技术记录心脏Na^+电流直接评估I类抗心律失常药物对Na^+通道的阻滞模式,并根据结果获得新的药物分类。我们使用通过胶原酶处理从豚鼠心脏分离的心室肌细胞。通过全细胞配置、细胞附着和内向外膜片配置的膜片钳技术记录Na^+电流,丙吡胺、I_a试剂产生具有两个指数函数、快速和慢速分量的Na^+电流的使用依赖性块。在不同外部pH下进行的实验进一步表明,缓慢的阻断过程是由具有与Na^+通道的激活状态结合的亲和力的电离形式的药物引起的,而快速的过程是由非电离形式与通道的激活状态结合产生的。快块和慢块的分数几乎相等。 I_b剂利多卡因也引起两次指数阻滞的发展,而阻滞发展的主要部分是由快部分引起的,小部分是由慢部分引起的。快速阻断是由非离子化药物与通道的失活状态结合而产生的,慢速阻断是由离子化药物与通道的激活状态结合引起的。与利多卡因类似,美西律也引起两个指数阻滞的发展。电离美西律PR

项目成果

期刊论文数量(16)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hiraoka,M.: "Bisaramil.A new class I antiarrhythmic agent." Cardiovasc.Drug Rev.11(in press). (1994)
Hiraoka,M.:“Bisaramil。一种新型 I 类抗心律失常药物。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
平岡 昌和: "不整脈 '93" メディカルレビュー社, (1993)
平冈正和:“心律失常 93”医学评论公司,(1993)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
平岡 昌和: "心筋細胞の電気生理学的パラメーターに対するクラスI抗不整脈薬の併用効果" Pharma Medica. 11. 137-140 (1993)
Masakazu Hiraoka:“联合 I 类抗心律失常药物对心肌细胞电生理参数的影响”Pharma Medica 11. 137-140 (1993)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sunami,A.: "Properties of veratridine-modified single Na^+ channels in guinea pig ventricular myocytes." Am.J.Physiol.264. H454-H463 (1993)
Sunami,A.:“豚鼠心室肌​​细胞中藜芦定修饰的单 Na+ 通道的特性。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HIRAOKA Masayasu其他文献

HIRAOKA Masayasu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HIRAOKA Masayasu', 18)}}的其他基金

Molecular Mechanism of QT Prolongation due to dysfunction of HERG K^+ Channels
HERG K^通道功能障碍导致QT延长的分子机制
  • 批准号:
    10470161
  • 财政年份:
    1998
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Modulatory mechanisms of cardiac ion channels.
心脏离子通道的调节机制。
  • 批准号:
    07044233
  • 财政年份:
    1995
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Study of intracellular modulation mechanisms of cardiac ATP-sensitive K^+ channels and their pathophysiological implications.
心脏 ATP 敏感 K^ 通道的细胞内调节机制及其病理生理学意义的研究。
  • 批准号:
    07457165
  • 财政年份:
    1995
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Investigation of pathophysiological properties of ion channels on cardiac sarcoplasmic reticulum.
心脏肌浆网离子通道病理生理特性的研究。
  • 批准号:
    05044151
  • 财政年份:
    1993
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Development of a ligand for purification of the ATP-sensitive K^+ channe protein
开发用于纯化 ATP 敏感 K^ 通道蛋白的配体
  • 批准号:
    02557039
  • 财政年份:
    1990
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
Physiological Modulations of Cardiac K^+ Currents by Ca^<2+> and their Roles for Arrhythmogenesis
Ca^2 对心脏 K^ 电流的生理调节及其在心律失常发生中的作用
  • 批准号:
    01480245
  • 财政年份:
    1989
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Study of the outward current systems of mammalian ventricular muscle cells in relation to the genesis of rhythm disturbances
哺乳动物心室肌细胞外向电流系统与节律紊乱发生关系的研究
  • 批准号:
    62480214
  • 财政年份:
    1987
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
The study of the mechanism and characteristics of triggered-activity
触发活动机制及特征研究
  • 批准号:
    60480229
  • 财政年份:
    1985
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Role of the ATP-dependent chromatin-remodeling enzyme Brg1 in the regulation of cardiac Na+ channel
ATP依赖性染色质重塑酶Brg1在心脏Na通道调节中的作用
  • 批准号:
    10820211
  • 财政年份:
    2022
  • 资助金额:
    $ 8.13万
  • 项目类别:
Role of the ATP-dependent chromatin-remodeling enzyme Brg1 in the regulation of cardiac Na+ channel
ATP依赖性染色质重塑酶Brg1在心脏Na通道调节中的作用
  • 批准号:
    10705353
  • 财政年份:
    2022
  • 资助金额:
    $ 8.13万
  • 项目类别:
Structural basis of venom peptides that inhibit a Na+ channel regulator of pain
抑制疼痛 Na 通道调节剂的毒液肽的结构基础
  • 批准号:
    10415506
  • 财政年份:
    2021
  • 资助金额:
    $ 8.13万
  • 项目类别:
Study on the role of cardiac Na channel complexes in infantile onset congenital long QT syndrome.
心脏Na通道复合物在婴儿期先天性长QT综合征中的作用研究
  • 批准号:
    20K08170
  • 财政年份:
    2020
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanism of voltage-gated Na+ channel inhibition by ciguatoxin analogs (CTXs)
雪卡毒素类似物 (CTX) 抑制电压门控 Na 通道的分子机制
  • 批准号:
    20K06246
  • 财政年份:
    2020
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A study on the functional structures in the extracellular domain of a peptide-gated Na+ channel
肽门控Na通道胞外域功能结构的研究
  • 批准号:
    18K06337
  • 财政年份:
    2018
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Influence of neonatal variants in cardiac Na channel mutations causing severe arrhythmias
新生儿变异对导致严重心律失常的心脏Na通道突变的影响
  • 批准号:
    18K07858
  • 财政年份:
    2018
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of the unique voltage-dependent mechanism of a Na+ channel by voltage-clamp fluorometry
通过电压钳荧光法分析 Na 通道独特的电压依赖性机制
  • 批准号:
    16K19000
  • 财政年份:
    2016
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
A study on the functional importance of the inner space of the extracellular domain in a peptide-gated Na+ channel
肽门控Na通道胞外结构域内部空间功能重要性的研究
  • 批准号:
    15K07149
  • 财政年份:
    2015
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Utility of novel Na Channel Slow Inactivation Enhancers in Myotonia
新型Na通道慢失活增强剂在肌强直中的效用
  • 批准号:
    8927905
  • 财政年份:
    2014
  • 资助金额:
    $ 8.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了